|

Insulin Clinical Trials

12 actively recruiting trials across 6 locations

Also known as: Humalog, Hyperinsulinemic euglycemic clamp, Lantus, Levemir, Lispro, NPH

Other5 trials

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
Phase 2
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
Insulin Sensitivity After Breast Cancer
N/A
Insulin Therapy for Postreperfusion Hyperglycemia
Phase 4
Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients
N/A

Rochester, New York2 trials

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

University of Rochester Medical Center

N/A
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)

University of Rochester Medical Center

N/A

Tuscaloosa, Alabama1 trial

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

University of Alabama

Phase 4

San Francisco, California1 trial

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

University of California San Francisco - Mission Bay- Site Number : 8400012

Phase 2

Atlanta, Georgia1 trial

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

Grady Health System

Phase 4

Charlottesville, Virginia1 trial

GDM: Insulin with or Without Metformin?

University of Virginia

Phase 4

Milwaukee, Wisconsin1 trial

Gestational Diabetes and Pharmacotherapy (GAP)

Medical College of Wisconsin

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.